Medical News

---

• MACCE risk from OAT interruption may outweigh bleeding benefit
• PCI ‘should be recommended’ for AMI with RBBB
• Vitamin D status associated with β-cell function and glycemia
• GLP-1 increases myocardial blood flow but not glucose uptake
• Psoriasis increases risk for poor pregnancy outcomes
• MACCE risk from OAT interruption may outweigh bleeding benefit

MACCE risk from OAT interruption may outweigh bleeding benefit Posted: 22 Sep 2011 05:00 PM PDT Patients with coronary stents undergoing an invasive procedure have a high risk for a perioperative major adverse cardiac and cerebrovascular event after interruption of oral antiplatelet therapy, say French scientists.

PCI ‘should be recommended’ for AMI with RBBB Posted: 22 Sep 2011 05:00 PM PDT Primary percutaneous coronary intervention should be included in guidelines for the management of acute myocardial infarction with right bundle branch block, suggest a team of Czech and South African researchers.

Vitamin D status associated with β-cell function and glycemia Posted: 22 Sep 2011 05:00 PM PDT Vitamin D levels may predict changes in β-cell function and glycemic status, researchers report.

GLP-1 increases myocardial blood flow but not glucose uptake Posted: 22 Sep 2011 05:00 PM PDT Exenatide infusion does not increase myocardial glucose uptake in Type 2 diabetes patients, but seems to increase myocardial blood flow through a separate mechanism, suggest findings presented at the 47th annual meeting of the European Association for the Study of Diabetes in Lisbon, Portugal.

Psoriasis increases risk for poor pregnancy outcomes Posted: 22 Sep 2011 05:00 PM PDT Women with psoriasis are at increased risk for having a preterm birth and low-birth-weight infants compared with those without the condition, suggest study findings.

MACCE risk from OAT interruption may outweigh bleeding benefit Posted: 22 Sep 2011 05:00 PM PDT Patients with coronary stents undergoing an invasive procedure have a high risk for a perioperative major adverse cardiac and cerebrovascular event after interruption of oral antiplatelet therapy, say French scientists.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610